AdvaMed Statement on HHS Rescission of Policies on Laboratory Developed Tests During COVID and Beyond
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement: “AdvaMed fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle…